Gliomas, glioneural and neuronal tumours_ CNS 5 WHO 2021 Flashcards
What types of tumours are included in the tumour group “Adult-type diffuse gliomas”?
- Astrocytoma, IDH-mutant
- Oligodendroglioma, IDH-mutant and 1p/19q-codeleted
- Glioblastoma, IDH-wildtype
What types of tumours are included in the tumour group “Paediatric-type diffuse low-grade gliomas”?
- Diffuse astrocytoma, MYB- or MYBL1-altered
- Angiocentric glioma
- Polymorphous low-grade neuroepithelial tumour of the young
- Diffuse low-grade glioma, MAPK pathway-altered
What types of tumours are included in the tumour group “Paediatric-type diffuse high-grade gliomas”?
Diffuse midline glioma, H3 K27-altered
- Diffuse hemispheric glioma, H3 G34-mutant
- Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype
- Infant-type hemispheric glioma
What types of tumours are included in the tumour group “Circumscribed astrocytic gliomas”?
- Pilocytic astrocytoma
- High-grade astrocytoma with piloid features
- Pleomorphic xanthoastrocytoma
- Subependymal giant cell astrocytoma
- Chordoid glioma
- Astroblastoma, MN1-altered
What types of tumours are included in the tumour group “Glioneuronal and neuronal tumours”?
- Ganglioglioma
- Desmoplastic infantile ganglioglioma/desmoplastic infantile astrocytoma
- Dysembryoplastic neuroepithelial tumour DNET
- Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters
- Papillary glioneuronal tumour
- Rosette-forming glioneuronal tumour
- Myxoid glioneuronal tumour
- Diffuse leptomeningeal glioneuronal tumour
- Gangliocytoma
- Multinodular and vacuolating neuronal tumour
- Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease)
- Central neurocytoma
- Extraventricular neurocytoma
- Cerebellar liponeurocytoma
What types of tumours are included in the tumour group “Ependymomas”?
- Supratentorial ependymoma
- Supratentorial ependymoma (ZFTA or YAP1 fusion-positive)
- Posterior fossa ependymoma
- Posterior fossa ependymoma (PFA or PFB group)
- Pinal ependymoma
- Spinal ependymoma, MYCN amplified
- Myxopapillary ependymoma
- Subependymoma
What does ATRX mutation stand for?
Alpha-thalassemia/mental retardation syndrome X
What does “CDKN2A/B” stand for?
Cyclin-dependent kinase inhibitor 2A/B
What does “EGFR” stand for?
Epidermal growth factor receptor
What does “H3 G34” stand for?
Histone H3 3 G34
What does “H3 K27M” stand for?
Histone H3 K27M
In what glioma type/s is “ZFTA fusions” clinically relevant?
- Present in some supratentorial ependymomas (ZFTA: previously named RELA fusions)
What does “IDH1/2” mutation stand for?
Isocitrate dehydrogenase
What does “MAPK” stand for?
Mitogen-activated protein kinase pathway
What does “MGMT” stand for?
methylation O6-methylguanine DNA methyltransferase
In what glioma type/s is “Gain of chromosome 7/loss of chromosome 10 (+ 7/ − 10)” clinically relevant?
- Common in glioblastoma IDH-wildtype CNS WHO grade 4
What does “TERTp” stand for?
Telomerase reverse transcriptase promotor
What does “YAP1 “ stand for?
Yes-associated protein 1
what does “ZFTA” stand for?
Zinc finger translocation associated
In what glioma type/s is “Loss of chromosome 1p and 19q (loss of heterozygosity) (1p/19q codeletion)” clinically relevant?
- Prerequisite for the diagnosis of oligodendroglioma
In what glioma type/s is “H3 K27M mutation” clinically relevant?
- One of the criteria of diffuse midline glioma, H3 K27M altered
- May occur in other gliomas not located in the midline (pilocytic astrocytoma and ependymoma)
In what glioma type/s is “H3 G34 mutation
Histone H3 3 G34” clinically relevant?
- Present in hemispheric diffuse glioma, IDH-wildtype, predominantly in children and young adults, poor prognosis
In what glioma type/s is “EGFR-mutations” clinically relevant?
- Common in glioblastoma, IDH-wildtype CNS WHO grade 4
- If present in astrocytoma, IDH-wildtype CNS WHO grades 2 or 3, it is consistent with glioblastoma, IDH-wildtype CNS WHO grade 4
In what glioma type/s is “EGFR-mutations” clinically relevant?
- Most common is EGFRvIII, frequently present in glioblastoma, IDH-wildtype CNS WHO grade 4
In what glioma type/s is “H3 G34 mutation” clinically relevant?
- Present in hemispheric diffuse glioma, IDH-wildtype, predominantly in children and young adults, poor prognosis